{
    "clinical_study": {
        "@rank": "119590", 
        "brief_summary": {
            "textblock": "The purpose of this study is the use of buprenorphine/naloxone in treatment of opioid\n      dependence."
        }, 
        "brief_title": "Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1", 
        "condition": [
            "Heroin Dependence", 
            "Substance-Related Disorders"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Heroin Dependence", 
                "Substance-Related Disorders", 
                "Opioid-Related Disorders"
            ]
        }, 
        "detailed_description": {
            "textblock": "The objective of this study is to determine the safety and efficacy of a\n      buprenorphine/naloxone combination tablet for opiate dependence treatment."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        DSM-IV diagnosis of current opiate dependence males and non-pregnant, non-nursing female\n        18-59 yrs of age\n\n        Exclusion Criteria:\n\n        Any significant medical condition AST or ALT levels greater than 3x's the upper limit of\n        normal level Current Axis I diagnosis other than opiate, caffeine or nicotine dependence"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "59 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "0", 
        "firstreceived_date": "April 18, 2001", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00015171", 
            "org_study_id": "NIDA-5-0013-1", 
            "secondary_id": "Y01-5-0013-1"
        }, 
        "intervention": {
            "intervention_name": "Buprenorphine/naloxone", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Buprenorphine", 
                "Naloxone"
            ]
        }, 
        "lastchanged_date": "November 3, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10010"
                }, 
                "name": "New York MDRU"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "CS1008 A&B Eff/Safety Trial of BUP/NX for the Treatment of Opiate Dependence", 
        "overall_official": {
            "affiliation": "New York MDRU", 
            "last_name": "John Rotrosen, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 3", 
        "primary_outcome": [
            {
                "measure": "Craving"
            }, 
            {
                "measure": "Drug use"
            }, 
            {
                "measure": "Retention"
            }, 
            {
                "measure": "Opioid withdrawal"
            }, 
            {
                "measure": "Subjective rating"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00015171"
        }, 
        "source": "National Institute on Drug Abuse (NIDA)", 
        "sponsors": {
            "collaborator": {
                "agency": "New York MDRU", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "April 1996", 
        "study_design": "Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 1999"
    }, 
    "geocoordinates": {
        "New York MDRU": "40.714 -74.006"
    }
}